Sign Up to Receive Your Personalised Learning Resources

JOURNALS
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Start Learning
World Cancer Day 2025: “United by Unique”
Global Liver Institute launches #OctoberIs4Livers campaign to combat rising liver cancer rates
Key insights in gynecological malignancies: BrUOG 354, AGO-OVAR 2.29/ENGOT-ov34, KEYVIBE-005, CARACO
A personal drive to make a difference: Dr Michael K. Gibson’s career in gastrointestinal oncology
Focus on leukemia – Felix and ASC4FIRST
Project Cure CRC Awards Nearly $5 Million to Accelerate Advancements in Care
Navigating treatment choices in high-risk early-stage melanoma
CE/CME ACCREDITED
Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors
CE/CME ACCREDITED
Mesothelioma and Immunotherapies
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
CE/CME ACCREDITED
World Cancer Day 2025: “United by Unique”
Global Liver Institute launches #OctoberIs4Livers campaign to combat rising liver cancer rates
Key insights in gynecological malignancies: BrUOG 354, AGO-OVAR 2.29/ENGOT-ov34, KEYVIBE-005, CARACO
A personal drive to make a difference: Dr Michael K. Gibson’s career in gastrointestinal oncology
Focus on leukemia – Felix and ASC4FIRST
Project Cure CRC Awards Nearly $5 Million to Accelerate Advancements in Care
Navigating treatment choices in high-risk early-stage melanoma
CE/CME ACCREDITED
Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors
CE/CME ACCREDITED
Mesothelioma and Immunotherapies
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
CE/CME ACCREDITED
World Cancer Day 2025: “United by Unique”
Global Liver Institute launches #OctoberIs4Livers campaign to combat rising liver cancer rates
Key insights in gynecological malignancies: BrUOG 354, AGO-OVAR 2.29/ENGOT-ov34, KEYVIBE-005, CARACO
A personal drive to make a difference: Dr Michael K. Gibson’s career in gastrointestinal oncology
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Greatest hits of 2024
View
Trastuzumab deruxtecan shows clinical benefit in patients with HER2-ultralow metastatic breast cancer
View
Transarterial chemoembolization with lenvatinib and pembrolizumab showed improvement in progression-free survival for hepatocellular carcinoma
View
Project Cure CRC Awards Nearly $5 Million to Accelerate Advancements in Care
View
ESGO 24: Advances in cervical, endometrial and ovarian cancer
View
Overcoming Barriers in Liver Cancer Care: An Interview with Larry R Holden, CEO of Global Liver Institute
View
FDA Priority Review fast-tracks zongertinib for advanced NSCLC patients
View
From clinical trials to clinical practice: Applying CDK4/6 inhibitors in HR+/HER2– early breast cancer
View
Dr Elene Mariamidze on world-renowned mentors and resilience: touchONCOLOGY Future Leader 2025
View
Dr Pooja Ghatalia on research, mentorship and patient-centered care: touchONCOLOGY Future Leader 2025
View
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGY
Sign me up!